In recent years, many marine resources have attracted attention in the search for bioactive compounds to develop new drugs. We have taken note of brown algae of the genus Sargassum (Sargassacea, Fucales), which contain structurally unique secondary metabolites such as palstoquinones, 1, 2) chromanol, 3, 4) and chromenes. 5) In the course of studies on search for bioactive molecules of algae, we isolated plastoquinones [hydroquinone (1) and quinone (2)] together with a novel chromene derivative (3) from a brown alga, Sargassum micracanthum (KUETZING) ENDLICHER, "Togemoku" in Japanese (Fig. 1) .
chromanol, 3, 4) and chromenes. 5) In the course of studies on search for bioactive molecules of algae, we isolated plastoquinones [hydroquinone (1) and quinone (2) ] together with a novel chromene derivative (3) from a brown alga, Sargassum micracanthum (KUETZING) ENDLICHER, "Togemoku" in Japanese ( Fig. 1) . 6) 1 and 3 exhibited antioxidant activity, while 2 and 3 exhibited antiviral effect on human cytomegalovirus. 6) Osteoporosis, a disease characterized by low bone mass and structural deterioration of bone tissue, has been widely recognized as one of major public health problems. In order to prevent or treat osteoporosis, it is quite important to find novel candidates of lead compound for the development of clinically useful drugs. Thus, we evaluated the effects of 1, 2 and 3 on bone resorption. This paper describes their inhibitory effects on osteoclast-like cells (OCLs) formation, pit formation and survival of OCLs.
MATERIALS AND METHODS

Preparation of Osteoclast-Like Cells
Bone marrow cells were isolated from 7-week-old male ddY mice (Sankyo Lab. Service) as described previously. 7) The bone marrow cells (1ϫ10 7 cells) were suspended in 10 ml of a-MEM supplemented with 10% FBS, and incubated for 24 h with 10 ng/ml macrophage-colony stimulating factor (M-CSF) (recombinant human, Wako Pure Chemical Industries, Ltd.). Nonadherent cells were used as osteoclast progenitor cells [M-CSF-dependent (MD) cells] in the OCL formation and survival experiments. MD cells (1ϫ10 5 cells/100 ml) were added to 96-well plates with 10 ng/ml M-CSF and 100 ng/ml sRANKL (recombinant human, Wako Ltd.) in the absence or presence of test compounds and cultured for 6 d. Adherent cells were then stained for tartrate-resistant acid phosphatase (TRAP) activity as previously described. 7 Ϫ6 M PGE 2 (Sigma) using collagen-precoated dishes. After culturing for 7 d, the dishes were treated with 0.2% bacterial collagenase, and the OCLs were collected and resuspended in a-MEMϩ10% FBS to be used to assay pit formation assay.
Dentin Resorption Assay The assay for dentine resorption by OCLs was performed as previously described. 9) Briefly, the dentine slices were placed into the wells of 96-well plate containing 0.1 ml a-MEM supplemented with 10% FBS. OCL preparation (1.3ϫ10 3 cells) suspended in 0.1 ml of the same medium was transferred onto the slices. After incubation for 90 min at 37°C, the slices were placed into the wells of 24-well plates containing a-MEMϩ10% We evaluated inhibitory effects of plastoquinones (1, 2) and chromene derivative (3) from the methanol extract of Sargassum micracanthum on the differentiation of osteoclast progenitors into osteoclast-like cells (OCLs), bone-resorbing activity and the survival of OCLs. When OCL formation was investigated using osteoclast progenitor cells obtained from macrophage-colony stimulating factor (M-CSF)-treated mouse bone marrow, 1-3 inhibited dose-dependently OCL formation at the concentrations of 3-10 m mM, the order of inhibitory potency being 1Ͼ3Ͼ2. In addition, they suppressed dose-dependently the pit formation induced by OCL on dentine slices, the order of inhibitory potency being 1Ͼ3Ͼ2. The survival of OCLs was inhibited by about 35, 45 and 60% in the presence of 6 m mM of 2, 3 and 1, respectively. These results suggest that the inhibitory effects of the three compounds on the differentiation, pit formation and the survival of OCLs might contribute to the suppression of bone resorption.
Key words plastoquinone; Sargassum micracanthum; bone resorption; differentiation; osteoclast survival FBS with or without test compounds (0.5 ml/well) and treated for 48 h at 37°C. The slices were stained with 0.1% Borax solution containing 0.1% toluidine blue. The number of resorption pits was counted under the microscope.
OCL Survival Assay MD cells (1ϫ10 6 cells/dish) were cultured for 10 d in a-MEM supplemented with 10% FBS, sRANKL (100 ng/ml) and M-CSF (50 ng/ml) using collagenprecoated dishes. The dishes were then treated with collagenase, and OCLs were collected and resuspended in a-MEM containing 10% FBS. OCLs (2.6ϫ10 3 cells/100 ml) were added into each well of 96-well plate with or without test compounds and cultured for 24 h. The cells were then stained for TRAP activity. TRAP(ϩ) OCLs containing three or more nuclei were counted as surviving OCLs.
Statistical Analysis Data are expressed as the meanϮ S.E.M. The statistical significance of the difference between the control and the experimental group was determined using Student's t-test.
RESULTS
Inhibitory Effects of 1, 2 and 3 on OCL Formation
As shown in Fig. 2B , sRANKL induced OCL formation in MD cells cultured for 6 d, although the absence of sRANKL did not induce OCL formation, and elcatonin (ECT), a specific inhibitor of bone resorption, depressed sRANKL-induced OCL formation at 2 U/ml (data not shown). As indicated in Figs. 2A, C-E, 1, 2 and 3 inhibited the OCL formation induced by sRANKL at 3-10 mM in a dose-dependent manner, and the order of inhibitory potency was 1Ͼ3Ͼ2.
Inhibitory Effects of 1, 2 and 3 on Pit Formation As shown in Fig. 3B , OCLs formed abundant pits on dentine slices in the absence of the compounds during 2 d-culturing. ECT inhibited pit formation by about 60% at 2 U/ml (data not shown). As shown in Figs. 3A, C-E, the number of pits formed in the presence of each compound was decreased with increasing the concentrations of each compound. The order of the inhibitory potency for pit formation was 1Ͼ3Ͼ2 at 6 and 10 mM.
Inhibitory Effects of 1, 2 and 3 on the Survival of OCLs After OCLs were cultured in the absence of the compound for 24 h, the number of TRAP-positive OCLs decreased by 24% (Fig. 4C ) compared with that before culturing as indicated in Fig. 4B (before culture: 617.3Ϯ1.86, after culture: 456.0Ϯ19.3, pϽ0.01 vs. before culture). ECT decreased the survival of OCLs at 2 U/ml (317Ϯ6.8**, ** pϽ0.01 vs. control) (Fig. 4G) . As shown in Fig. 4A, 2 inhibited the survival of OCLs by about 35 and 35% at 6 and 10 mM, respectively. 3 inhibited the survival of OCLs by about 45 and 35% at 6 and 10 mM, respectively. The inhibitory effects of 2 and 3 were not dose-dependent, while 1 dose-dependently inhibited the survival of OCLs (Fig. 4A) . The order of inhibitory potency of these compounds at 6 mM was 1Ͼ3Ͼ2.
DISCUSSION
In the previous study, 1, 2 and 3 were found to exihibit significant antioxidant activities such as inhibitory effect on lipid peroxidation and radical scavenging effect on 1,1-diphenyl-2-picrylhydrazyl (DPPH). 6) In the present study, these compounds inhibited both OCL and pit formation. The order of their inhibitory potency on OCL and pit formation was similar to that of inhibitory potency on lipid peroxidation activity rather than that of reducing effect on DPPH. 6) This finding suggests that the inhibitory effects of 1, 2 and 3 on OCL formation and bone resorption might be due to their antioxidant activities. A part of this suggestion may be supported by the report 10) that antioxidants like pyrrolidine dithiocarbamate (PDTC) and N-acetyl cystein (NAC) decreased bone resorption.
OCLs are cells known to produce high amount of reactive oxygen species (ROS) and these free radicals play an important role not only in bone resorption, 11) but also in the process of OCL differentiation. 12) Additionally, antioxidants like PDTC, a specific inhibitor of NF-kB, and NAC can oppose ROS effects. On the other hand, PTDC was also reported to stimulate apoptosis of rabbit mature OCLs, which resulted in the inhibition of bone resorption. 13) This indicates that the NF-kB signaling cascade is closely involved in the prevention of apoptosis of OCLs. 14) In the present study, especially 1 decreased the survival of OCLs in a dose-dependent manner (Fig. 4) , which was similar to its inhibition of pit formation (Fig. 3) . This suggests that the decrease in the survival of OCLs partly results in the suppression of bone resorption. Further study is required in order to confirm the action mechanisms of 1-3 in their exertion of bone resorption inhibition.
In conclusion, three compounds isolated from S. micracanthum inhibited osteoclastogenesis, pit formation and survival activity of OCLs, suggesting that they could be candidate agents for prevention of bone diseases such as osteoporosis.
